Related Experiment Video
Updated: May 13, 2025

The Bovine Lung in Biomedical Research: Visually Guided Bronchoscopy, Intrabronchial Inoculation and In Vivo Sampling Techniques
Published on: July 3, 2014
Oral hydration is an effective adjuvant treatment for bovine respiratory disease
Júlia Miró1, Lorenzo Fraile1,2, Ramon Armengol1,2
1Animal Science Department, Universitat de Lleida, Lleida, Spain.
Abstract:
This study aimed to ascertain if oral hydration is an effective adjuvant treatment for bovine respiratory disease. To achieve this objective, clinical and performance outcomes were compared between the calves affected by bovine respiratory disease (BRD) treated with an antibiotic (florfenicol) and a non-steroidal anti-inflammatory drug (NSAID - meloxicam) [group not hydrated (GNH)] and the calves receiving the same antibiotic and NSAID plus an adjuvant therapy based on oral hydration [group hydrated (GH)] at 7% of the body weight (BW) for 5 days. A group of healthy calves, from the same batch and age, was also included as negative control. Crossbred calves (Aberdeen Angus-Holstein Frisian) were enrolled based on a clinical BRD score (0-3 points per clinical sign: rectal temperature, nasal discharge, eye discharge, cough, and ear/head position) during the first 21 days of the fattening period. Thus, a calf was designated BRD-affected if it had a BRD score equal to or higher than 5 points. The BRD-affected calves (n = 130) were randomly allocated to the GH (n = 65) or GNH (n = 65) groups. Clinical score was monitored after 4 days to determine curation or retreatment. Performance outcomes [body weight (BW) and average daily gain (ADG)] were also measured in both experimental groups and in the negative control group at days of inclusion (42 and 80 days) since the beginning of the trial. Throughout the trial, GH showed a significantly (p ≤ 0.05) lower clinical score after 4 days and a complete absence of BRD cases becoming chronic compared to GNH. When BW data were analyzed using a multivariable model, considering BW at day 0 as a factor in the model to accurately estimate BW2, BW3, ADG2, ADG3, and ADG global, GH calves showed significantly (p ≤ 0.05) higher ADG throughout the trial (at 42 days, 42-80 days, and inclusion-80 days) compared to the GNH ones. In this study, fattening calves with clinical BRD, receiving antibiotic and NSAIDs plus an adjuvant therapy, based on oral hydration at 7% of their BW for 5 days, had better curation rate, less chronic cases, and better performance parameters compared to calves that only received antibiotic and NSAIDs.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: